ื‘ืขืœื™ื? ืขื“ื›ืŸ ืืช ืคืจื˜ื™ ื”ืืกื™ืžื•ืŸ ืฉืœืš ื‘ื—ื™ื ื.
ๆญฃ
๐Ÿ”Š

ๆญฃ
/
๐Ÿ”Š

ืžื—ื™ืจ Tetratricopeptides (ๆญฃ)
โ€0.01894ย โ€$
116.61Kโ€ ๐Ÿ”Š
ื ืคื— ื‘-24 ืฉืขื•ืช
โ€150.53ย โ€$
ื ื–ื™ืœื•ืช
โ€517.24ย โ€$
ืžื—ื–ื™ืงื™ื
N/A
ื’ื™ืœ
4 ื—ื•ื“ืฉื™ื
ื”ืขืจื›ืช ืฉื•ื•ื™ ื‘ื“ื™ืœื•ืœ ืžืœื
$145.92Kโ€
ืฉื•ื•ื™ ืฉื•ืง
$145.92Kโ€
5 ื“ืงื•ืช
1 ืฉืขื”
6 ืฉืขื•ืช
24 ืฉืขื•ืช
ื›ืžื•ืชTxns
โ€150.53ย โ€$
18
ืงื ื”
ืžื›ื•ืจ
8
10

ืžืื’ืจื™ื ืื—ืจื™ื ืฉืกื•ื—ืจื™ื ื‘ืžื˜ื‘ืข Tetratricopeptides (ๆญฃ)

โ’ถ/ๆญฃ
PulseXPulseX
ื ื–ื™ืœื•ืช$193.26Kโ€ื›ืžื•ืชโ€2,489.47ย โ€$
ๆญฃ/WPLS
PulseX V2PulseX V2
ื ื–ื™ืœื•ืชโ€4,675.37ย โ€$ื›ืžื•ืชโ€2,402.28ย โ€$
ๆญฃ/โ—‡โ™ชโ™ซโœถโ˜‰
PulseX V2PulseX V2
ื ื–ื™ืœื•ืชโ€8,920.79ย โ€$ื›ืžื•ืชโ€870.92ย โ€$
ๆญฃ/๎ค
PulseXPulseX
ื ื–ื™ืœื•ืชโ€1,810.03ย โ€$ื›ืžื•ืชโ€275.24ย โ€$
ๆญฃ/DAI
PulseX V2PulseX V2
ื ื–ื™ืœื•ืชโ€2,901.30ย โ€$ื›ืžื•ืชโ€217.99ย โ€$

ืกื˜ื˜ื™ืกื˜ื™ืงื” ืฉืœ ืžื—ื™ืจื™ ๆญฃ/๐Ÿ”Š

ื”ืžื—ื™ืจ ื”ื ื•ื›ื—ื™ ืฉืœ ๆญฃ (ๆญฃ/๐Ÿ”Š) ื‘-PulseX ื”ื•ื โ€0.01894ย โ€$, ื”ืžื—ื™ืจ ืขืœื” ื‘-0.36% ื‘-24 ื”ืฉืขื•ืช ื”ืื—ืจื•ื ื•ืช. ืขืœ ืคื™ ื“ื™ื•ื•ื—ื™ื, ื ืคื— ื”ืžืกื—ืจ ื‘-24 ืฉืขื•ืช ื”ื•ื ืขื•ืžื“ ืขืœโ€150.53ย โ€$ ืขื ืกื”"ื› 18 ืขืกืงืื•ืช. ื›ืชื•ื‘ืช ื”ื—ื•ื–ื” ืฉืœ ๆญฃ/๐Ÿ”Š ื”ื™ื 0x81d081d6631e50115237180cd40387fb6c13f6d7, ืขื ืฉื•ื•ื™ ื‘ื“ื™ืœื•ืœ ืžืœื (FDV) ืฉืœ $149.79Kโ€ ื•ืžืื’ืจ ื ื–ื™ืœื•ืช ืฉืœ โ€517.24ย โ€$.